What Are the Fundamentals Of Teladoc Health (TDOC)?

By Blake Campbell • Thursday, October 27 12:00 • Permanent Link

Shares of Health Information Services company Teladoc Health jumped 6.4% today. With many investors piling into TDOC without a second thought, it may be a good idea to take a closer look at the stock. Here are some quick facts to get you started:

Teladoc Health has moved -82.1% over the last year, and the S&P 500 logged a change of -16.7%
TDOC has an average analyst rating of hold and is -18.04% away from its mean target price of $34.7 per share
Its trailing earnings per share (Eps) is $-43.41
Teladoc Health has a trailing 12 month Price to Earnings (P/E) ratio of -0.7 while the S&P 500 average is 15.97
Its forward earnings per share (Eps) is $-43.41 and its forward P/E ratio is -19.3
The company has a Price to Book (P/B) ratio of 0.8 in contrast to the S&P 500's average ratio of 2.95
Teladoc Health is part of the Healthcare sector, which has an average P/E ratio of 13.21 and an average P/B of 4.07
The company has a free cash flow of $242,727,504, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

At Market Interference, we believe in giving retail investors access to timely and accurate data to help inform their investment decisions. subscribe to our free newsletter today to keep track of each day's market movers!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.